Xenon Pharmaceuticals Inc XENE:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:31 PM EDT
37.16quote price arrow up+0.20 (+0.54%)
Volume
175,075
52 week range
23.26 - 41.39
Loading...
  • Open36.73
  • Day High37.80
  • Day Low36.11
  • Prev Close36.96
  • 52 Week High41.39
  • 52 Week High Date08/11/22
  • 52 Week Low23.26
  • 52 Week Low Date12/06/21

Key Stats

  • Market Cap2.314B
  • Shares Out62.26M
  • 10 Day Average Volume0.39M
  • Dividend-
  • Dividend Yield-
  • Beta1.43
  • YTD % Change19.01

KEY STATS

  • Open36.73
  • Day High37.80
  • Day Low36.11
  • Prev Close36.96
  • 52 Week High41.39
  • 52 Week High Date08/11/22
  • 52 Week Low23.26
  • 52 Week Low Date12/06/21
  • Market Cap2.314B
  • Shares Out62.26M
  • 10 Day Average Volume0.39M
  • Dividend-
  • Dividend Yield-
  • Beta1.43
  • YTD % Change19.01

RATIOS/PROFITABILITY

  • EPS (TTM)-1.72
  • P/E (TTM)-21.66
  • Fwd P/E (NTM)-15.67
  • EBITDA (TTM)-86.89M
  • ROE (TTM)-17.51%
  • Revenue (TTM)21.16M
  • Gross Margin (TTM)12.82%
  • Net Margin (TTM)-433.95%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/08/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Xenon Pharmaceuticals Inc

 

Content From Our Affiliates

Profile

MORE
Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapeutics to improve the lives of patients with neurological disorders, with a focus on epilepsy. The Company is focused on advancing its ion channel neurology pipeline. The Company's products within its novel proprietary pipeline include clinical-stage candidates XEN496 and XEN1101, which are focused on treating neurological disorders, with a particular focus on...
Simon Pimstone Ph.D.
Executive Chairman of the Board
Ian Mortimer
President, Chief Executive Officer, Director
Sherry Aulin CPA
Chief Financial Officer
James Empfield Ph.D.
Executive Vice President - Drug Discovery
Robin Sherrington Ph.D.
Executive Vice President - Strategy and Innovation
Address
3650 Gilmore Way
Vancouver, BC
V5G 4W8
Canada

Top Peers

SYMBOLLASTCHG%CHG
ROIV
Roivant Sciences Ltd
3.96+0.32+8.79%
SAGE
SAGE Therapeutics Inc
40.90-0.33-0.81%
RXDX
Prometheus Biosciences Inc
58.40-1.17-1.96%
ISEE
IVERIC bio Inc
20.50+0.72+3.64%
FATE
Fate Therapeutics Inc
22.62-1.21-5.08%